Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Traumatic Brain Injury
NCT05195996Phase 4Completed
- Sponsor
- Menoufia University
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of propranolol in traumatic brain injury (TBI) (2 arms), sponsored by Menoufia University. Primary endpoint: Survival at 7 days. Started Oct 2021; status: completed.
02
Drugs
propranolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05195996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195996.